Protein Engineering for Therapeutics, Part B - 1st Edition - ISBN: 9780123969620, 9780123972644

Protein Engineering for Therapeutics, Part B, Volume 503

1st Edition

Serial Volume Editors: K. Dane Wittrup Gregory L. Verdine
eBook ISBN: 9780123972644
Hardcover ISBN: 9780123969620
Imprint: Academic Press
Published Date: 19th January 2012
Page Count: 392
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Volume in series  


Stapled Peptides for Intracellular Drug Targets

1. Introduction

2. All-Hydrocarbon Stapled α-Helical Peptides

3. The Design of Stapled Peptides

4. Stapled Peptide Synthesis

5. Olefin Metathesis

6. N-terminal and Internal Modifications

7. Cleavage of Stapled Peptides from the Solid Support

8. Stapled Peptide Purification

9. Biophysical Characterization

10. Cell Permeability

11. In Vitro Target Interaction and Activity Assays

12. In Vivo Efficacy

13. Strategies for Stapled Peptide Optimization

14. Summary


Mapping of Vascular ZIP Codes by Phage Display

1. Introduction

2. Methods

3. Concluding Remarks and Perspectives


Engineering Cyclic Peptide Toxins

1. Introduction

2. Peptide Design

3. Peptide Synthesis

4. Structural Analysis

5. Stability Assays

6. Special Considerations for Cyclic Peptides


Peptide Discovery Using Bacterial Display and Flow Cytometry

1. Introduction

2. Protocols

3. Conclusions


Designed Ankyrin Repeat Proteins (DARPins)

1. Introduction

2. Applications of DARPins

3. Protocols for DARPins in Biomedical Applications


Target-Binding Proteins Based on the 10th Human Fibronectin Type III Domain (10Fn3)

1. Introduction

2. Library Design

3. Choice of Selection Platform

4. Phage Display, mRNA Display, and Yeast-Surface Display of 10Fn3-Based Libraries

5. Production

6. Conclusion



1. Introduction

2. Cloning and Expression of Lipocalins and Anticalins in E. coli

3. Construction of a Genetic Anticalin Library

4. Preparation and Selection of a Phage Display Library for Anticalins

5. Preparation and Selection of a Bacterial Surface Display Library for Anticalins

6. Colony Screening for Anticalins with Specific Target-Binding Activity

7. Screening for Anticalins with Specific Target-Binding Activity Using Microtiter Plate Expression in E. coli

8. Measuring Target Affinity of Anticalins in an ELISA

9. Measuring Target Affinity of Anticalins via Surface Plasmon Resonance

10. Application of Anticalins in Biochemical Research and Drug Development

T Cell Receptor Engineering

1. Introduction

2. Stability and Affinity Engineering of T Cell Receptors by Yeast Surface Display

3. Affinity Engineering and Selection of T Cell Receptors by T Cell Display

4. Expression, Purification, and Applications of Soluble scTv Proteins

5. Recipes for Media and Buffers


Engineering Knottins as Novel Binding Agents

1. Introduction

2. Knottins as Scaffolds for Engineering Molecular Recognition

3. Engineering Knottins by Yeast Surface Display

4. Knottin Library Construction

5. Screening Yeast-Displayed Knottin Libraries

6. Knottin production by chemical synthesis or recombinant expression

7. Cell binding assays

8. Summary


Practical Theoretic Guidance for the Design of Tumor-Targeting Agents

1. Introduction

2. What Molecular Size Is Best for Tumor Uptake?

3. Will Targeting Increase Nanoparticle Accumulation in a Tumor?

4. How Does Affinity Affect Biodistribution?

5. What Dose Is Necessary in Order to Overcome the “Binding Site Barrier”?

6. Conclusions

Reengineering Biopharmaceuticals for Targeted Delivery Across the Blood–Brain Barrier

1. Introduction

2. Blood–Brain Barrier Receptor-Mediated Transport and Molecular Trojan Horses

3. Reengineering Recombinant Proteins for Targeted Brain Delivery

4. Genetic Engineering of Expression Plasmid DNA Encoding IgG Fusion Proteins

5. Pharmacokinetics and Brain Uptake of IgG Fusion Proteins

6. CNS Pharmacological Effects of IgG Fusion Proteins

7. Immune Response Against IgG Fusion Proteins

8. Summary

Engineering and Identifying Supercharged Proteins for Macromolecule Delivery into Mammalian Cells

1. Introduction

2. Methods

3. Conclusion


This volume of Methods in Enzymology looks at Protein Engineering for Therapeutics. The chapters provide an invaluable resource for academics, researchers and students alike. With an international board of authors, this volume is split into sections that cover subjects such as Peptides, and Scaffolds

Key Features

  • Chapters provide an invaluable resource for academics, researchers and students alike
  • Iinternational board of authors
  • This volume is split into sections that cover subjects such as peptides, and scaffolds


Biochemists, biophysicists, molecular biologists, analytical chemists, and physiologists


No. of pages:
© Academic Press 2012
Academic Press
eBook ISBN:
Hardcover ISBN:

Ratings and Reviews

About the Serial Volume Editors

K. Dane Wittrup Serial Volume Editor

Gregory L. Verdine Serial Volume Editor